Inspection: CDSCO may send a team to inspect the foreign site

Reliance on Recognized Authorities: In some cases, CDSCO may accept valid GMP certificates from:

• US FDA
• EMA
• MHRA
• TGA
• WHO PQP

Key Documentation Requirements

• Form 40: Application for registration of a drug and/or manufacturing site
• GMP Certificate: Issued by the national competent authority in exporting country
• Site Master File (SMF): Detailed overview of manufacturing and quality operations
• Product Dossiers: Including manufacturing process, stability studies, and quality control
• Batch release certificates and analytical methods
• Labeling samples and pack inserts

Foreign GMP Inspection Process by CDSCO

1. Applicant submits Form 40 with required fees and documentation
2. CDSCO evaluates technical and administrative completeness
3. Inspection team is deputed based on product type, risk, and site history
4. Inspectors evaluate:
   • SOP compliance, change control, and deviation management
   • Facility layout, material flow, personnel hygiene
   • Batch records, validation, and analytical test data
   • Data integrity and electronic record practices
5. Inspection findings are categorized and documented
6. Applicant receives a deficiency letter (if applicable) and must submit a CAPA plan
7. Upon satisfactory review, Form 41 (Registration Certificate) is issued

Common Deficiencies Identified in Imported Drug Inspections

• Outdated or incomplete GMP certificates
• Missing SMF elements or lack of facility-specific data
• Inadequate control over outsourced activities
• Absence of validated analytical methods or cleaning procedures
• Improper handling of out-of-specification results
• Lack of ALCOA+ compliance in computerized systems

Best Practices for Importers and Foreign Manufacturers

1. Maintain current and complete GMP documentation as per Schedule D(1)
2. Align quality systems with Indian GMP expectations, particularly Schedule M
3. Prepare for virtual or on-site inspection by conducting internal mock audits
4. Submit all requested information in English or bilingual format
5. Include timelines and responsibility assignment in CAPA responses

Timeframes and Processing Timelines

• Registration Certificate (Form 41): Typically processed within 6–9 months
• Import License (Form 10): Issued after Form 41 approval and verification of product dossier
• Inspections may extend the timeline if significant deficiencies are found

Fees and Logistics

• Application fees vary by dosage form and number of sites
• Applicants must bear the cost of CDSCO inspector travel and accommodation
• Expenses must be paid upfront prior to foreign site visits

How CDSCO Coordinates with Other Global Agencies

• CDSCO engages in bilateral discussions with agencies like:
  • US FDA
  • EMA
  • WHO Prequalification Programme
• Relies on mutual recognition in select cases but does not grant automatic acceptance
• Foreign GMP certificates must still be verified and assessed for authenticity and scope

Conclusion

Compliance with India’s inspection requirements for imported drugs is a multi-step process involving documentation, potential site audits, and alignment with CDSCO expectations. By preparing proactively, ensuring robust GMP systems, and maintaining transparency with the regulator, foreign manufacturers and their Indian partners can expedite market access while avoiding delays or import rejections. With India continuing to expand its regulatory oversight globally, adherence to CDSCO inspection frameworks is critical for long-term commercial success.